Inhibition of growth of human malignant glioblastoma in nude mice by antagonists of bombesin/gastrin-releasing peptide

Oncogene

Volumn 18, Issue 50, 1999, Pages 7168-7173

  Kiaris, H ^a,b   Schally, A V ^a,b   Sun, B ^a,b   Armatis, P ^a   Groot, K ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Autocrine; Brain tumors; Cancer therapy; Oncogene stimulation; Paracrine; Peptide analogs

Indexed keywords

BOMBESIN; BOMBESIN RECEPTOR; GASTRIN RELEASING PEPTIDE; MESSENGER RNA; PEPTIDE HORMONE ANTAGONIST; RC 3095; RC 3940; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; GLIOBLASTOMA; HUMAN CELL; MOUSE; NONHUMAN; ONCOGENE C FOS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TUMOR VOLUME; XENOGRAFT;

ANIMALIA; BOVINE RESPIRATORY SYNCYTIAL VIRUS; MUS MUSCULUS;

EID: 0033604465     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1203213     Document Type: Article

References (35)

1. Draoui M, Chung P, Park M, Birrer M, Jakowlew S and Moody TW. (1995). Peptides, 16, 289-292.
2. Draoui M, Moody TW, Fahti Z and Battey J. (1993). Cell Growth Differ., 4, 723-729.
3. Halazonetis TD, Georgopoulos K, Greenberg ME and Leder P. (1988). Cell, 55, 917-924
4. Halmos G and Schally AV. (1997). Proc. Natl. Acad. Sci. USA, 94, 956-960.
5. Hochberg F and Pruitt A. (1987). In: Harrison's Principles of Internal Medicine, 11th ed. Braunwald E, Isselbacher KJ, Petersdorf RG, Wilson JD, Martin JB and Fauci S (eds.) McGraw-Hill: New York, pp. 1968-1980.
6. Koppan M, Halmos G, Arencibia JM, Lamharzi N and Schally AV. (1998). Cancer, 83, 1335-1343.
7. Liebow C, Crean DH, Lee MT, Kamer AR, Mang TS and Schally AV. (1994). Proc. Natl. Acad. Sci. USA, 91, 3804-3808.
8. Mahmoud S, Staley J, Taylor J, Bogden A, Moreau J-P, Coy D, Avis I, Cuttitta F, Mulshine JL, Moody TW. (1991). Cancer Res., 51, 1798-1802.
9. Moody TW and Pert CB. (1979). Biochem. Biophys. Res. Commun., 90, 7-14.
10. Moody TW, Mahmoud S, Staley J, Naldini L, Cirillo D, South V, Felder S and Kris R. (1989). J. Mol. Neurosci., 1, 235-242.
11. Moody TW, Murphy A, Mahmoud S and Fiskum G. (1987). Biochem. Biophys. Res. Commun., 147, 189-195.
12. Moody TW, Pert CB, Gazdar AF, Carney DN and Minna JD. (1981). Science, 214, 1246-1248.
13. O'Shea EK, Rutkowski R, Stafford WF 3d and Kim PS. (1989). Science, 245, 646-648.
14. Olson JJ, Beck DW, MacIndoe JW and Min-Loh P. (1988). Cancer, 61, 952-957.
15. Paoletti P, Butti G, Zibera C, Scerrati C, Gibelli N, Roselli R, Magrassi L, Sica G, Rossi G and Della Cuna GR. (1990). J. Neurosurg., 73, 736-742.
16. Pinski J, Halmos G, Shirahige Y, Wittliff JL and Schally AV. (1993). J. Clin. Endocrinol. Metab., 77, 1388-1392.
17. Pinski J, Halmos G, Yano T, Szepeshazi K, Qin Y, Ertl T and Schally AV. (1994b). Int. J. Cancer, 57, 574-580.
18. Pinski J, Reile H, Halmos G, Groot K and Schally AV. (1994c). Cancer Res., 54, 169-174.
19. Pinski J, Schally AV, Halmos G, Szepeshazi K, Groot K, O'Byrne K and Cai R-Z. (1994a). Br. J. Cancer, 70, 886-892.
20. Pinski J, Schally AV, Halmos G, Szepeshazi K and Groot K. (1994d). Cancer Res., 54, 5895-5901.
21. Poisson M, Pertuiset BF, Hauw J-J, Philippon J, Buge A, Moguilewsky M and Philibert D. (1983). J. Neurooncol., 1, 179-189.
22. Qin Y, Ertl T, Cai R-Z, Halmos G and Schally AV. (1994a). Cancer Res., 54, 1035-1041.
23. Qin Y, Halmos G, Cai R-Z, Szoke B, Ertl T and Schally AV. (1994b). J. Cancer Res. Clin. Oncol., 120, 519-528.
24. Radulovic S, Cai R-Z, Serfozo P, Groot K, Redding TW, Pinski J and Schally AV. (1991). Int. J. Pept. Protein Res., 38, 593-600.
25. Reile H, Cai R-Z, Armatis P and Schally AV. (1995). Int. J. Oncol., 7, 749-754.
26. Schally AV and Comaru-Schally AM. (1997). In: Cancer Medicine, 4th Ed. Holland JF, Frei III F., Bast Jr RC., Kufe DE, Morton DL and Weichselbaum RR. (eds) Williams and Wilkins Publishers: Baltimore, pp. 1067-1086.
27. Sharif TR, Luo W and Sharif M. (1997) Mol. Cell Endocrinol., 130, 119-130
28. Schoenberg BS. (1983). In: Oncology of the Nervous System. Walker MD. (ed.) Nijhoff: Boston, USA, pp. 1-30.
29. Siegfried JM, Han Y-H, DeMichele MAA, Hunt JD, Gaither AL and Cuttitta F. (1994). J. Biol. Chem., 269, 8596-8603.
30. Spindel ER, Giladi E, Segerson TP and Nagalla S. (1993). Rec. Prog. Horm. Res., 48, 365-391.
31. Staley J, Coy DH, Jensen RT and Moody TW. (1993). J. Mol. Neurosci., 4, 29-50.
32. Szepeshazi K, Schally AV, Cai R-Z, Radulovic, S, Milovanovic S and Szoke B. (1991). Cancer Res., 51, 5980-5986.
33. Szepeshazi K, Schally AV, Halmos G, Groot K and Radulovic S. (1992). J. Natl. Cancer Inst., 84, 1915-1921.
34. Wang QJ, Knezetic JA, Schally AV, Pour PM and Adrian TE. (1996). Int. J. Cancer, 68, 1-7.
35. Yano T, Pinski J, Groot K and Schally AV. (1992). Cancer Res., 52, 4545-4547.